NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
72 hedge funds and large institutions have $99.3M invested in Novelion Therapeutics Inc. Common Shares in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
100% less call options, than puts
Call options by funds: $3K | Put options by funds: $632K
Holders
72
Holding in Top 10
3
Calls
$3K
Puts
$632K
Top Buyers
| 1 | +$7.3M | |
| 2 | +$4.24M | |
| 3 | +$773K | |
| 4 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$352K |
| 5 |
State Street
Boston,
Massachusetts
|
+$208K |
Top Sellers
| 1 | -$6.92M | |
| 2 | -$4.15M | |
| 3 | -$2.59M | |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$2.1M |
| 5 |
Renaissance Technologies
New York
|
-$1.35M |